Safety and health care utilization following COVID-19 vaccination (BNT162b2) among children and youth with juvenile idiopathic arthritis and inflammatory bowel disease: A population-based study
Overall, this study demonstrates the safety of the BNT162b2 vaccine in children/youths with JIA and IBD, with no associated increase in AESI or health care use.
Authors
- Jessica Widdifield (ORCID: https://orcid.org/0000-0002-7464-0460)
- Jennifer J. Lee (ORCID: https://orcid.org/0000-0002-5300-2662)
- Rae S. M. Yeung (ORCID: https://orcid.org/0000-0003-2361-725X)
- Eric I. Benchimol (ORCID: https://orcid.org/0000-0001-8855-3598)
- Sasha Bernatsky (ORCID: https://orcid.org/0000-0002-9515-2802)
- Jeffrey C. Kwong (ORCID: https://orcid.org/0000-0002-7820-2046)
- Qing Li (ORCID: https://orcid.org/0000-0001-7139-464X)
Institutions
- Sunnybrook Health Science Centre (CA)
- 3M (United States) (US)
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- McGill University Health Centre (CA)
- International Council for the Exploration of the Sea (DK)
- Public Health Ontario (CA)
- SickKids Foundation (CA)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
Publication Details
- Journal
- Paediatrics & Child Health
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1093/pch/pxae101
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Public Health Agency of Canada
- Department of Family and Community Medicine, University of Toronto